annual EBITDA:
$501.40M+$55.30M(+12.40%)Summary
- As of today (May 22, 2025), SGRY annual EBITDA is $501.40 million, with the most recent change of +$55.30 million (+12.40%) on December 31, 2024.
- During the last 3 years, SGRY annual EBITDA has risen by +$100.40 million (+25.04%).
- SGRY annual EBITDA is now at all-time high.
Performance
SGRY EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$98.20M-$62.80M(-39.01%)Summary
- As of today (May 22, 2025), SGRY quarterly EBITDA is $98.20 million, with the most recent change of -$62.80 million (-39.01%) on March 31, 2025.
- Over the past year, SGRY quarterly EBITDA has dropped by -$11.50 million (-10.48%).
- SGRY quarterly EBITDA is now -39.01% below its all-time high of $161.00 million, reached on December 31, 2024.
Performance
SGRY quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$489.90M-$11.50M(-2.29%)Summary
- As of today (May 22, 2025), SGRY TTM EBITDA is $489.90 million, with the most recent change of -$11.50 million (-2.29%) on March 31, 2025.
- Over the past year, SGRY TTM EBITDA has increased by +$14.20 million (+2.99%).
- SGRY TTM EBITDA is now -2.29% below its all-time high of $501.40 million, reached on December 31, 2024.
Performance
SGRY TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
SGRY EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +12.4% | -10.5% | +3.0% |
| 3 y3 years | +25.0% | -23.2% | +11.7% |
| 5 y5 years | +61.7% | +116.8% | +69.3% |
SGRY EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +25.0% | -39.0% | +22.6% | -2.3% | +18.8% |
| 5 y | 5-year | at high | +80.5% | -39.0% | +130.5% | -2.3% | +97.5% |
| alltime | all time | at high | +744.3% | -39.0% | +209.4% | -2.3% | +2078.4% |
SGRY EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $98.20M(-39.0%) | $489.90M(-2.3%) |
| Dec 2024 | $501.40M(+12.4%) | $161.00M(+44.9%) | $501.40M(+6.0%) |
| Sep 2024 | - | $111.10M(-7.1%) | $472.90M(-0.1%) |
| Jun 2024 | - | $119.60M(+9.0%) | $473.30M(-0.5%) |
| Mar 2024 | - | $109.70M(-17.2%) | $475.70M(+6.6%) |
| Dec 2023 | $446.10M(-3.0%) | $132.50M(+18.8%) | $446.10M(+2.0%) |
| Sep 2023 | - | $111.50M(-8.6%) | $437.40M(+1.8%) |
| Jun 2023 | - | $122.00M(+52.3%) | $429.80M(+4.2%) |
| Mar 2023 | - | $80.10M(-35.3%) | $412.30M(-10.4%) |
| Dec 2022 | $460.00M(+14.7%) | $123.80M(+19.2%) | $460.00M(-2.9%) |
| Sep 2022 | - | $103.90M(-0.6%) | $473.70M(+3.3%) |
| Jun 2022 | - | $104.50M(-18.2%) | $458.60M(+4.5%) |
| Mar 2022 | - | $127.80M(-7.1%) | $438.80M(+9.4%) |
| Dec 2021 | $401.00M(+44.3%) | $137.50M(+54.8%) | $401.00M(+4.1%) |
| Sep 2021 | - | $88.80M(+4.8%) | $385.30M(+13.6%) |
| Jun 2021 | - | $84.70M(-5.9%) | $339.10M(+5.1%) |
| Mar 2021 | - | $90.00M(-26.1%) | $322.50M(+16.1%) |
| Dec 2020 | $277.80M(-10.4%) | $121.80M(+185.9%) | $277.80M(+12.0%) |
| Sep 2020 | - | $42.60M(-37.4%) | $248.00M(-12.3%) |
| Jun 2020 | - | $68.10M(+50.3%) | $282.80M(-2.2%) |
| Mar 2020 | - | $45.30M(-50.8%) | $289.30M(-6.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | $310.00M(+113.5%) | $92.00M(+18.9%) | $310.00M(+68.4%) |
| Sep 2019 | - | $77.40M(+3.8%) | $184.10M(+9.1%) |
| Jun 2019 | - | $74.60M(+13.0%) | $168.70M(+9.3%) |
| Mar 2019 | - | $66.00M(-294.7%) | $154.30M(+6.3%) |
| Dec 2018 | $145.20M(-37.5%) | -$33.90M(-154.7%) | $145.20M(-18.9%) |
| Sep 2018 | - | $62.00M(+3.0%) | $179.10M(+52.9%) |
| Jun 2018 | - | $60.20M(+5.8%) | $117.10M(+10.4%) |
| Mar 2018 | - | $56.90M(+15.8%) | $106.06M(-54.2%) |
| Jun 2017 | - | $49.16M(-10.0%) | $231.55M(-4.7%) |
| Mar 2017 | - | $54.59M(-30.9%) | $243.05M(+4.6%) |
| Dec 2016 | $232.30M(+291.2%) | $78.97M(+61.7%) | $232.30M(+265.5%) |
| Sep 2016 | - | $48.83M(-19.5%) | $63.55M(-6.0%) |
| Jun 2016 | - | $60.65M(+38.3%) | $67.61M(+19.8%) |
| Mar 2016 | - | $43.85M(-148.8%) | $56.42M(-5.0%) |
| Dec 2015 | $59.39M(-9.8%) | -$89.78M(-269.8%) | $59.39M(-60.9%) |
| Sep 2015 | - | $52.88M(+6.9%) | $152.00M(+25.0%) |
| Jun 2015 | - | $49.47M(+5.7%) | $121.61M(+68.6%) |
| Mar 2015 | - | $46.81M(+1550.1%) | $72.14M(+184.8%) |
| Dec 2014 | $65.87M(-5.8%) | $2.84M(-87.4%) | $25.33M(+12.6%) |
| Sep 2014 | - | $22.49M | $22.49M |
| Dec 2013 | $69.89M(-2.5%) | - | - |
| Dec 2012 | $71.66M | - | - |
FAQ
- What is Surgery Partners annual EBITDA?
- What is the all time high annual EBITDA for Surgery Partners?
- What is Surgery Partners annual EBITDA year-on-year change?
- What is Surgery Partners quarterly EBITDA?
- What is the all time high quarterly EBITDA for Surgery Partners?
- What is Surgery Partners quarterly EBITDA year-on-year change?
- What is Surgery Partners TTM EBITDA?
- What is the all time high TTM EBITDA for Surgery Partners?
- What is Surgery Partners TTM EBITDA year-on-year change?
What is Surgery Partners annual EBITDA?
The current annual EBITDA of SGRY is $501.40M
What is the all time high annual EBITDA for Surgery Partners?
Surgery Partners all-time high annual EBITDA is $501.40M
What is Surgery Partners annual EBITDA year-on-year change?
Over the past year, SGRY annual EBITDA has changed by +$55.30M (+12.40%)
What is Surgery Partners quarterly EBITDA?
The current quarterly EBITDA of SGRY is $98.20M
What is the all time high quarterly EBITDA for Surgery Partners?
Surgery Partners all-time high quarterly EBITDA is $161.00M
What is Surgery Partners quarterly EBITDA year-on-year change?
Over the past year, SGRY quarterly EBITDA has changed by -$11.50M (-10.48%)
What is Surgery Partners TTM EBITDA?
The current TTM EBITDA of SGRY is $489.90M
What is the all time high TTM EBITDA for Surgery Partners?
Surgery Partners all-time high TTM EBITDA is $501.40M
What is Surgery Partners TTM EBITDA year-on-year change?
Over the past year, SGRY TTM EBITDA has changed by +$14.20M (+2.99%)